Home > Drug Search >
  • company_query: AMRIF
  •   > 
Drug Filter
Category:
chemistry (9) biology (22)
Status:
Approved (2) Phase Ⅲ (1) Phase Ⅱ (15) Phase Ⅰ (13)
Clinical Stage:
Pending (4) Active (21) Discontinued (4)
Bio-Type:
Cell therapy (1) Vaccine (16) Blood extraction (1) Recombinant enzyme (1) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Breast cancer (1) Gastric cancer (1) HIV infection (1) Melanoma (4) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (1) Type 2 diabetes (1) Head and neck cancer (1) Inhalational anthrax (1) Colorectal cancer (2) Venezuelan equine encephalitis virus infection (1) Fungal infection (1) Age-related macular degeneration (AMD) (1) Malaria (1) Type 1 diabetes (1) Viral hemorrhagic fever (1) Hereditary orotic aciduria (1) Mitochondrial myopathies (1) Glioblastoma (2) Graft versus host disease (1) Mesothelioma (1) Dengue fever (2) Chemotherapy induced poisoning (1)
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top